Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Gastroenterology

One-Year Survival Rate and Factors Associated with Stage IV Colorectal Cancer at National General Hospital in Indonesia

Provisionally accepted
Ardy  WildanArdy Wildan1*Eunike  Vania ChristabelEunike Vania Christabel1Ikhwan  RinaldiIkhwan Rinaldi2Murdani  AbdullahMurdani Abdullah1Dadang  MakmunDadang Makmun1
  • 1University of Indonesia, Depok, Indonesia
  • 2Universitas Indonesia, Depok, Indonesia

The final, formatted version of the article will be published soon.

Objective : To evaluate one-year survival and identify mortality-associated factors in stage IV colorectal cancer patients in Indonesia. Patients and Methods : A retrospective cohort study was conducted using medical records of 214 patients aged ≥18 years who were diagnosed with stage IV CRC at Cipto Mangunkusumo National General Hospital between January 2018 and May 2020. Variables analyzed included demographic characteristics, body mass index (BMI), and chemotherapy status. Survival analysis was performed using the Kaplan-Meier method and Cox proportional hazards model. Results : Key findings included a one-year mortality rate of 53.3% and a median survival of 9.0 months (IQR 3.0-12.0). Most patients were under 60 years old (66.8%), and 47% were underweight (BMI <18.5 kg/m²). Multivariate analysis revealed that a BMI <18.5 kg/m² (HR: 1.49) and lack of chemotherapy (HR: 4.47) significantly predicted increased mortality. Multivariate analysis revealed that a BMI <18.5 kg/m² (HR: 1.49) and lack of chemotherapy (HR: 4.47) were independently associated with higher one-year mortality. However, the observed survival difference related to chemotherapy may be influenced by patient selection and baseline clinical condition. Conclusion : This study demonstrates poor one-year survival among stage IV colorectal cancer patients in Indonesia. Underweight status and non-receipt of chemotherapy were independently associated with higher mortality; however, chemotherapy status likely reflects underlying patient fitness and disease severity rather than a direct causal effect. These findings highlight the challenges of late presentation, poor nutritional status, and limited access to systemic therapy in resource-limited settings.

Keywords: Cancer, Colorecta cancer, factor associated, One-year survival rate, Stage IV colorectal cancer

Received: 05 Jan 2026; Accepted: 10 Feb 2026.

Copyright: © 2026 Wildan, Christabel, Rinaldi, Abdullah and Makmun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ardy Wildan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.